• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Momenta Pharmaceuticals to Present At the 3rd Annual Citi Biotech Day

Posted on: Thursday, 4 September 2008, 12:00 CDT

CAMBRIDGE, Mass., Sept. 4, 2008 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard Shea, Chief Financial Officer, will provide a corporate overview at the 3rd Annual Citi Biotech Day on Monday, September 8, 2008 at 1:05 p.m. EDT. The conference will be held at the Citi Executive Conference Center in New York City.

A live audio webcast of the presentation will be available on the "Investors" section of the Company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available through December 1, 2008.

About Momenta

Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. Momenta was founded in 2001 based on technology initially developed at Massachusetts Institute of Technology and is headquartered in Cambridge, MA.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

This news release was distributed by GlobeNewswire, www.globenewswire.com

CONTACT: Momenta Pharmaceuticals, Inc. Investor Relations Beverly Holley 617-395-5189

Source: PrimeNewswire

More News in this Category